Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Intralytix, a developer products for food safety, animal health and human therapeutics and probiotics, has signed multiple project collaboration agreement (MPCA) with The Procter & Gamble Company (P&G).
Subscribe to our email newsletter
Under the deal, both the firms have agreed to collaborate on the development of bacteriophage (or phage) based technology for a range of applications.
Intralytix CEO John Woloszyn said their phage-based technology is all natural and environmentally friendly and they look forward to this collaboration bringing forth new innovations.
"The company already has two FDA/USDA approved phage-based products on the market: ListShield, effective at substantially reducing or eliminating Listeria monocytogenes on food products, and EcoShield, effective at substantially reducing or eliminating E. coli O157:H7 on red meat intended for grinding," Woloszyn said.